Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to -$554,000.

  • Rockwell Medical's Net Income towards Common Stockholders fell 209.01% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 312.10%. This contributed to the annual value of -$554,000 for FY2024, which is 93.68% up from last year.
  • Latest data reveals that Rockwell Medical reported Net Income towards Common Stockholders of -$554,000 as of FY2024, which was up 93.68% from -$8.8 million recorded in FY2023.
  • Over the past 5 years, Rockwell Medical's Net Income towards Common Stockholders peaked at -$554,000 during FY2024, and registered a low of -$32.7 million during FY2021.
  • For the 3-year period, Rockwell Medical's Net Income towards Common Stockholders averaged around -$9.3 million, with its median value being -$8.8 million (2023).
  • In the last 5 years, Rockwell Medical's Net Income towards Common Stockholders fell by 8.69% in 2021 and then spiked by 93.68% in 2024.
  • Yearly analysis of 5 years shows Rockwell Medical's Net Income towards Common Stockholders stood at -$30.1 million in 2020, then decreased by 8.69% to -$32.7 million in 2021, then soared by 42.82% to -$18.7 million in 2022, then spiked by 53.11% to -$8.8 million in 2023, then skyrocketed by 93.68% to -$554,000 in 2024.